SCHEMBL67608

SCHEMBL67608

Oc1c(Cl)cc(Cl)cc1Cc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.74
HSD17B10 Q99714 5/20 0.63
CYP3A4 P08684 5/20 0.63
CYP1A2 P05177 4/20 0.63
CYP2C9 P11712 3/20 0.63
CYP2C19 P33261 3/20 0.63
CYP2D6 P10635 1/20 0.63
ALDH1A1 P00352 4/20 0.62
TSHR P16473 3/20 0.62
RECQL P46063 3/20 0.62
HIF1A Q16665 5/20 0.57
HPGD P15428 5/20 0.55
PRMT1 Q99873 1/20 0.53
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
LMNA P02545 4/20 0.48
HTT P42858 4/20 0.48
MAPT P10636 4/20 0.48
HSPD1 P10809 3/20 0.48
ALOX15 P16050 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11341546 0.88 HSP90AA1 (0.61) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL11505512 0.85 HSD17B10 (0.62) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL18857466 0.84 HSP90AA1 (0.72) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL29577605 0.83 HSD17B10 (0.59) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL1907836 0.83 HSD17B10 (0.59) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL28903722 0.83 HSD17B10 (0.59) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL9993152 0.81 HSD17B10 (0.56) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL13816977 0.81 CYP3A4 (0.56) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL28784583 0.81 HSD17B10 (0.56) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL13888086 0.81 HSD17B10 (0.56) HSP90AA1HSD17B10CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915210-B2 Compositions and methods for disinfecting hard surfaces RECKITT BENCKISER (US) 2011-03-29 US claimed
EP-0735866-B1 ANTIMICROBIAL WIPE COMPOSITIONS PROCTER & GAMBLE (US) 2001-02-21 EP claimed
EP-4475961-B1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS UNILEVER IP HOLDINGS B V (NL) 2025-08-20 EP disclosed
EP-4475962-B1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS UNILEVER IP HOLDINGS B V (NL) 2025-08-06 EP disclosed
US-20250195386-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS CONOPCO, INC., D/B/A UNILEVER (US) 2025-06-19 US disclosed
US-20250195342-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS CONOPCO, INC., D/B/A UNILEVER (US) 2025-06-19 US disclosed
WO-2025085892-A2 SULFATE-FREE PERSONAL CARE COMPOSITIONS LUBRIZOL ADVANCED MATERIALS, INC. (US) 2025-04-24 WO disclosed
EP-4475961-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS Unilever IP Holdings B.V. (NL) 2024-12-18 EP disclosed
EP-4475962-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS Unilever IP Holdings B.V. (NL) 2024-12-18 EP disclosed
WO-2023152112-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS UNILEVER IP HOLDINGS B.V. (NL) 2023-08-17 WO disclosed
WO-2023152113-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS UNILEVER IP HOLDINGS B.V. (NL) 2023-08-17 WO disclosed
EP-0369249-A2 Process for the preparation of cyclic carbonates BAYER AG (DE) 1990-05-23 EP disclosed
US-4500339-A Adherent controlled release microbiocides containing hydrolyzable silanes YOUNG ROBERT W 1985-02-19 US disclosed
US-4312855-A FOR IMPROVING DEPOSITION OR RETENTION OF ACTIVE MATERIAL; HAIR CONDITIONERS, DETERGENTS COLGATE-PALMOLIVE COMPANY (US) 1982-01-26 US disclosed
US-4196250-A DIBENZO CROWN COMPOUNDS, COCCIDIOSTATS, ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-04-01 US disclosed
US-4010252-A POLYQUATERNARY AMMONIUM COMPOUND, DEODORANTS COLGATE-PALMOLIVE COMPANY (US) 1977-03-01 US disclosed
US-4009254-A UNSYMMETRICAL ETHERS; SUNSCREEN AGENTS COLGATE-PALMOLIVE COMPANY (US) 1977-02-22 US disclosed
US-3988318-A HYDROXY-PHENOLS; PLASTICIZERS GAF CORPORATION (US) 1976-10-26 US disclosed
US-3988351-A GERMICIDES, INSECTICIDES, PLASITICIZERS, ANTI-OXIDANTS, WOOD PRESERVATIVES GAF CORPORATION (US) 1976-10-26 US disclosed
US-3975280-A Storage-stable, readily-soluble detergent additives, coating compositions and process HENKEL & CIE G.M.B.H. (DT) 1976-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250195386-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS CTRC, CUTA, DSG1 HSP90AA1 4045/4885HSD17B10 3559/4885CYP3A4 3882/4885
US-20250195342-A1 DRY COMPOSITIONS AND METHODS FOR FORMING STABLE LIQUID CLEANSING FORMULATIONS CTRC, LPO, CHIT1 HSP90AA1 3900/4885HSD17B10 3570/4885CYP3A4 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.